Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India
· Delayed Price · Currency is INR 593.20
-6.55 (-1.09%)
Apr 25, 2025, 3:29 PM IST
Lincoln Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | - | 933.05 | 728.99 | 693.55 | 622.5 | 514.39 | Upgrade
|
| Depreciation & Amortization | - | 105.19 | 90.55 | 79.53 | 74.22 | 71.95 | Upgrade
|
| Other Amortization | - | 1.06 | 1.11 | 1.35 | 1.38 | 1.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 2.76 | -0.76 | 1.3 | 0.53 | 0.4 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -227.85 | -51.35 | -36.1 | -24.5 | -17.96 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 6.5 | -1.78 | 5.27 | 0.91 | 21.17 | Upgrade
|
| Other Operating Activities | - | -27.36 | -60.42 | -7.61 | 15.62 | 19.57 | Upgrade
|
| Change in Accounts Receivable | - | -260.86 | -202.12 | -31.19 | -100.83 | 190.16 | Upgrade
|
| Change in Inventory | - | -71.4 | 27.14 | -261.29 | 7.83 | -111.7 | Upgrade
|
| Change in Accounts Payable | - | 215.73 | -205.14 | 145.93 | 55.5 | 72.28 | Upgrade
|
| Change in Other Net Operating Assets | - | -44.64 | 66.39 | 170.6 | 39.54 | -7.43 | Upgrade
|
| Operating Cash Flow | - | 632.17 | 392.62 | 761.32 | 692.7 | 754.15 | Upgrade
|
| Operating Cash Flow Growth | - | 61.01% | -48.43% | 9.91% | -8.15% | 42.71% | Upgrade
|
| Capital Expenditures | - | -394.76 | -142.59 | -455.25 | -87.5 | -76.91 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.9 | 7.06 | 0.79 | 0.65 | 5.08 | Upgrade
|
| Divestitures | - | - | - | - | 0.5 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1.37 | -0.23 | - | - | - | Upgrade
|
| Investment in Securities | - | -248.05 | 106.14 | -125.3 | -439.99 | -143.5 | Upgrade
|
| Other Investing Activities | - | 305.47 | -140.95 | -81.26 | 16.15 | 12.74 | Upgrade
|
| Investing Cash Flow | - | -573.42 | -366.43 | -780.8 | -642.27 | -308.83 | Upgrade
|
| Short-Term Debt Issued | - | 200 | 193.57 | 20 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 8.1 | Upgrade
|
| Total Debt Issued | - | 200 | 193.57 | 20 | - | 8.1 | Upgrade
|
| Short-Term Debt Repaid | - | -209.02 | -195.02 | - | -38.33 | -262.6 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -5.2 | -7.21 | -30.84 | Upgrade
|
| Total Debt Repaid | - | -209.02 | -195.02 | -5.2 | -45.54 | -293.45 | Upgrade
|
| Net Debt Issued (Repaid) | - | -9.02 | -1.44 | 14.8 | -45.54 | -285.35 | Upgrade
|
| Common Dividends Paid | - | -30.05 | -30.05 | -30 | - | -60 | Upgrade
|
| Other Financing Activities | - | -12.74 | -13.52 | -10.36 | -11.91 | -32.24 | Upgrade
|
| Financing Cash Flow | - | -51.8 | -45.01 | -25.56 | -57.45 | -377.59 | Upgrade
|
| Net Cash Flow | - | 6.95 | -18.82 | -45.04 | -7.03 | 67.74 | Upgrade
|
| Free Cash Flow | - | 237.41 | 250.03 | 306.07 | 605.19 | 677.24 | Upgrade
|
| Free Cash Flow Growth | - | -5.05% | -18.31% | -49.43% | -10.64% | 78.66% | Upgrade
|
| Free Cash Flow Margin | - | 4.09% | 4.90% | 6.48% | 14.27% | 17.52% | Upgrade
|
| Free Cash Flow Per Share | - | 11.85 | 12.48 | 15.28 | 30.21 | 33.86 | Upgrade
|
| Cash Interest Paid | - | 12.74 | 13.52 | 10.36 | 11.91 | 19.91 | Upgrade
|
| Cash Income Tax Paid | - | 261.51 | 296.1 | 236.96 | 194.91 | 160.43 | Upgrade
|
| Levered Free Cash Flow | - | 46.9 | 44.59 | 62.93 | 493.48 | 420.33 | Upgrade
|
| Unlevered Free Cash Flow | - | 52.81 | 54.82 | 68.68 | 500.99 | 429.69 | Upgrade
|
| Change in Net Working Capital | - | 217.2 | 397.44 | 105.06 | -14.13 | -68.72 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.